← Leaderboards
Michael J Fried
University Of North Carolina Chapel Hill
$0
Attributed
$0
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 6
By mechanism
M01$0 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles Michael Van Der Horst$17,688,631
- Michael W Fried$8,954,521
- Robert S Brown$3,426,728
- Colin D Hall$6,763,979
- Robert Brown$2,236,004
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectChronic Disease /DisorderClinical ResearchDrug Screening /EvaluationHuman Therapy EvaluationInterferon AlphaHepatitis CCombination ChemotherapyRibavirinMicroorganism Disease ChemotherapyHepatitis C VirusDrug Administration Rate /DurationHepatitis B Virus GroupHepatitis BVirus ReplicationHepatitis B AntigensImmunotherapyVirus Infection MechanismVirus LoadAdenine AnalogLiver Disorder ChemotherapyPlacebosRelapse /RecurrenceReverse Transcriptase Inhibitors
Grant awards (20)
CHRONIC HEPATITIS C W/ INTRON &RIBAVIRIN COMBINATION THERAPY$0
M01 · FY2000 · RR
CHRONIC HEPATITIS C W/ INTRON &RIBAVIRIN COMBINATION THERAPY$0
M01 · FY2000 · RR
CHRONIC HEPATITIS C W/ INTRON &RIBAVIRIN COMBINATION THERAPY$0
M01 · FY2000 · RR
CHRONIC HEPATITIS C W/ INTRON &RIBAVIRIN COMBINATION THERAPY$0
M01 · FY2000 · RR
INTERFERON ALPHA-2A &RIBAVIRIN W/ REBETRON IN HCV INFECTION$0
M01 · FY2000 · RR
INTERFERON ALPHA-2A &RIBAVIRIN W/ REBETRON IN HCV INFECTION$0
M01 · FY2000 · RR
INTERFERON ALPHA-2A &RIBAVIRIN W/ REBETRON IN HCV INFECTION$0
M01 · FY2000 · RR
INTERFERON ALPHA-2A &RIBAVIRIN W/ REBETRON IN HCV INFECTION$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL IN HBEAG+ CHRONIC HEPATITIS B INFECTED PTS$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL IN HBEAG+ CHRONIC HEPATITIS B INFECTED PTS$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL IN HBEAG+ CHRONIC HEPATITIS B INFECTED PTS$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL IN HBEAG+ CHRONIC HEPATITIS B INFECTED PTS$0
M01 · FY2000 · RR
INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
INTERFERON WITH RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR
INTERFERON WITH RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR
INTERFERON WITH RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR
INTERFERON WITH RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR
FTC (EMTRICITABINE) IN HEPATITIS B VIRUS INFECTED PTS$0
M01 · FY2000 · RR